Biochemical detection of Aβ isoforms: Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

Todd E. Golde, Christopher B. Eckman, Steven G Younkin

Research output: Contribution to journalArticle

237 Citations (Scopus)

Abstract

Prior to the identification of the various abnormal proteins deposited as fibrillar aggregates in the Alzheimer's disease (AD) brain, there was tremendous controversy over the importance of the various lesions with respect to primacy in the pathology of AD. Nevertheless, based on analogy to systemic amyloidosis, many investigators believed that the amyloid deposits in AD played a causal role and that characterization of these deposits would hold the key to understanding this complex disease. Indeed, in retrospect, it was the initial biochemical purifications of the ~4 kDa amyloid β-peptide (Aβ) from amyloid deposits in the mid 1980s that launched a new era of AD research (Glenner and Wong, Biochem. Biophys. Res. Commun. 122 (1984) 1121-1135; Wong et al., Proc. Natl. Acad Sci. USA 82 (1985) 8729-8732; and Masters et al., Proc. Natl. Acad Sci. USA 82 (1985) 4245-4249). Subsequent studies of the biology of Aβ together with genetic studies of AD have all supported the hypothesis that altered Aβ metabolism leading to aggregation plays a causal role in AD. Although there remains controversy as to whether Aβ deposited as classic amyloid or a smaller, aggregated, form causes AD, the relevance of studying the amyloid deposits has certainly been proven. Despite the significant advances in our understanding of the role of Aβ in AD pathogenesis, many important aspects of Aβ biology remain a mystery. This review will highlight those aspects of Aβ biology that have led to our increased understanding of the pathogenesis of AD as well as areas which warrant additional study. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)172-187
Number of pages16
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1502
Issue number1
DOIs
StatePublished - Jul 26 2000

Fingerprint

Alzheimer Disease
Protein Isoforms
Amyloid Plaques
Amyloid
Amyloidosis
Research Personnel
Pathology
Brain
Research
Proteins

Keywords

  • Alzheimer's disease
  • Amyloid β protein precursor
  • Biomarker
  • ELISA
  • Protease

ASJC Scopus subject areas

  • Biophysics
  • Molecular Biology
  • Molecular Medicine

Cite this

Biochemical detection of Aβ isoforms : Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. / Golde, Todd E.; Eckman, Christopher B.; Younkin, Steven G.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1502, No. 1, 26.07.2000, p. 172-187.

Research output: Contribution to journalArticle

@article{ad91a9b0eea240c9b7ee4cfa0d5d3ead,
title = "Biochemical detection of Aβ isoforms: Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease",
abstract = "Prior to the identification of the various abnormal proteins deposited as fibrillar aggregates in the Alzheimer's disease (AD) brain, there was tremendous controversy over the importance of the various lesions with respect to primacy in the pathology of AD. Nevertheless, based on analogy to systemic amyloidosis, many investigators believed that the amyloid deposits in AD played a causal role and that characterization of these deposits would hold the key to understanding this complex disease. Indeed, in retrospect, it was the initial biochemical purifications of the ~4 kDa amyloid β-peptide (Aβ) from amyloid deposits in the mid 1980s that launched a new era of AD research (Glenner and Wong, Biochem. Biophys. Res. Commun. 122 (1984) 1121-1135; Wong et al., Proc. Natl. Acad Sci. USA 82 (1985) 8729-8732; and Masters et al., Proc. Natl. Acad Sci. USA 82 (1985) 4245-4249). Subsequent studies of the biology of Aβ together with genetic studies of AD have all supported the hypothesis that altered Aβ metabolism leading to aggregation plays a causal role in AD. Although there remains controversy as to whether Aβ deposited as classic amyloid or a smaller, aggregated, form causes AD, the relevance of studying the amyloid deposits has certainly been proven. Despite the significant advances in our understanding of the role of Aβ in AD pathogenesis, many important aspects of Aβ biology remain a mystery. This review will highlight those aspects of Aβ biology that have led to our increased understanding of the pathogenesis of AD as well as areas which warrant additional study. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Aβ, Alzheimer's disease, Amyloid β protein precursor, Biomarker, ELISA, Protease",
author = "Golde, {Todd E.} and Eckman, {Christopher B.} and Younkin, {Steven G}",
year = "2000",
month = "7",
day = "26",
doi = "10.1016/S0925-4439(00)00043-0",
language = "English (US)",
volume = "1502",
pages = "172--187",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Biochemical detection of Aβ isoforms

T2 - Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

AU - Golde, Todd E.

AU - Eckman, Christopher B.

AU - Younkin, Steven G

PY - 2000/7/26

Y1 - 2000/7/26

N2 - Prior to the identification of the various abnormal proteins deposited as fibrillar aggregates in the Alzheimer's disease (AD) brain, there was tremendous controversy over the importance of the various lesions with respect to primacy in the pathology of AD. Nevertheless, based on analogy to systemic amyloidosis, many investigators believed that the amyloid deposits in AD played a causal role and that characterization of these deposits would hold the key to understanding this complex disease. Indeed, in retrospect, it was the initial biochemical purifications of the ~4 kDa amyloid β-peptide (Aβ) from amyloid deposits in the mid 1980s that launched a new era of AD research (Glenner and Wong, Biochem. Biophys. Res. Commun. 122 (1984) 1121-1135; Wong et al., Proc. Natl. Acad Sci. USA 82 (1985) 8729-8732; and Masters et al., Proc. Natl. Acad Sci. USA 82 (1985) 4245-4249). Subsequent studies of the biology of Aβ together with genetic studies of AD have all supported the hypothesis that altered Aβ metabolism leading to aggregation plays a causal role in AD. Although there remains controversy as to whether Aβ deposited as classic amyloid or a smaller, aggregated, form causes AD, the relevance of studying the amyloid deposits has certainly been proven. Despite the significant advances in our understanding of the role of Aβ in AD pathogenesis, many important aspects of Aβ biology remain a mystery. This review will highlight those aspects of Aβ biology that have led to our increased understanding of the pathogenesis of AD as well as areas which warrant additional study. Copyright (C) 2000 Elsevier Science B.V.

AB - Prior to the identification of the various abnormal proteins deposited as fibrillar aggregates in the Alzheimer's disease (AD) brain, there was tremendous controversy over the importance of the various lesions with respect to primacy in the pathology of AD. Nevertheless, based on analogy to systemic amyloidosis, many investigators believed that the amyloid deposits in AD played a causal role and that characterization of these deposits would hold the key to understanding this complex disease. Indeed, in retrospect, it was the initial biochemical purifications of the ~4 kDa amyloid β-peptide (Aβ) from amyloid deposits in the mid 1980s that launched a new era of AD research (Glenner and Wong, Biochem. Biophys. Res. Commun. 122 (1984) 1121-1135; Wong et al., Proc. Natl. Acad Sci. USA 82 (1985) 8729-8732; and Masters et al., Proc. Natl. Acad Sci. USA 82 (1985) 4245-4249). Subsequent studies of the biology of Aβ together with genetic studies of AD have all supported the hypothesis that altered Aβ metabolism leading to aggregation plays a causal role in AD. Although there remains controversy as to whether Aβ deposited as classic amyloid or a smaller, aggregated, form causes AD, the relevance of studying the amyloid deposits has certainly been proven. Despite the significant advances in our understanding of the role of Aβ in AD pathogenesis, many important aspects of Aβ biology remain a mystery. This review will highlight those aspects of Aβ biology that have led to our increased understanding of the pathogenesis of AD as well as areas which warrant additional study. Copyright (C) 2000 Elsevier Science B.V.

KW - Aβ

KW - Alzheimer's disease

KW - Amyloid β protein precursor

KW - Biomarker

KW - ELISA

KW - Protease

UR - http://www.scopus.com/inward/record.url?scp=0034718027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034718027&partnerID=8YFLogxK

U2 - 10.1016/S0925-4439(00)00043-0

DO - 10.1016/S0925-4439(00)00043-0

M3 - Article

C2 - 10899442

AN - SCOPUS:0034718027

VL - 1502

SP - 172

EP - 187

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 1

ER -